Combining stem cells and genes for effective therapeutics.
作者信息
Ye Zhaoyang, Mahato Ram I
出版信息
Mol Pharm. 2011 Oct 3;8(5):1443-5. doi: 10.1021/mp200437m.
Abstract
摘要
相似文献
1
Combining stem cells and genes for effective therapeutics.
Mol Pharm. 2011 Oct 3;8(5):1443-5. doi: 10.1021/mp200437m.
2
Progress and prospects: gene therapy clinical trials (part 2).
Gene Ther. 2007 Nov;14(22):1555-63. doi: 10.1038/sj.gt.3303033.
3
Genetic modification of stem cells for improved therapy of the infarcted myocardium.
Mol Pharm. 2011 Oct 3;8(5):1446-57. doi: 10.1021/mp2001318. Epub 2011 Jun 8.
4
Recent developments in gene transfer: risk and ethics.
BMJ. 2005 Jan 8;330(7482):79-82. doi: 10.1136/bmj.330.7482.79.
5
Five years of vector service for gene therapy.
Trends Genet. 2002 Mar;18(3):118-9. doi: 10.1016/s0168-9525(01)02603-8.
6
Recent advances in the use of encapsulated cells for effective delivery of therapeutics.
Ther Deliv. 2010 Sep;1(3):387-96. doi: 10.4155/tde.10.36.
7
Gene therapy revisited. In spite of problems and drawbacks, gene therapy moves forward.
EMBO Rep. 2001 Dec;2(12):1064-5. doi: 10.1093/embo-reports/kve260.
8
Gene therapy as a novel pharmaceutical intervention for stroke.
Curr Pharm Des. 2011;17(5):424-33. doi: 10.2174/138161211795164149.
9
Nanotechnology shaping stem cell therapy: Recent advances, application, challenges, and future outlook.
Biomed Pharmacother. 2021 May;137:111236. doi: 10.1016/j.biopha.2021.111236. Epub 2021 Jan 21.
10
Genome medicine: gene therapy for the millennium.
Pharmacogenomics. 2002 Jan;3(1):15-8. doi: 10.1517/14622416.3.1.15.
本文引用的文献
1
Transplanted induced pluripotent stem cells improve cardiac function and induce neovascularization in the infarcted hearts of db/db mice.
Mol Pharm. 2011 Oct 3;8(5):1602-10. doi: 10.1021/mp2003576. Epub 2011 Sep 8.
2
Development of novel efficient SIN vectors with improved safety features for Wiskott-Aldrich syndrome stem cell based gene therapy.
Mol Pharm. 2011 Oct 3;8(5):1525-37. doi: 10.1021/mp200132u. Epub 2011 Aug 31.
3
Gene-modified adult stem cells regenerate vertebral bone defect in a rat model.
Mol Pharm. 2011 Oct 3;8(5):1592-601. doi: 10.1021/mp200226c. Epub 2011 Sep 13.
4
Utilizing cell-matrix interactions to modulate gene transfer to stem cells inside hyaluronic acid hydrogels.
Mol Pharm. 2011 Oct 3;8(5):1582-91. doi: 10.1021/mp200171d. Epub 2011 Aug 24.
5
Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
Mol Pharm. 2011 Oct 3;8(5):1538-48. doi: 10.1021/mp200137c. Epub 2011 Aug 19.
6
Glioma gene therapy using induced pluripotent stem cell derived neural stem cells.
Mol Pharm. 2011 Oct 3;8(5):1515-24. doi: 10.1021/mp200127u. Epub 2011 Jul 22.
7
Stem cell based cancer gene therapy.
Mol Pharm. 2011 Oct 3;8(5):1480-7. doi: 10.1021/mp200151a. Epub 2011 Jul 25.
8
Hematopoietic stem cell gene therapy as a treatment for autoimmune diseases.
Mol Pharm. 2011 Oct 3;8(5):1488-94. doi: 10.1021/mp2001523. Epub 2011 Jul 13.
9
A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma.
Mol Pharm. 2011 Oct 3;8(5):1559-72. doi: 10.1021/mp200161f. Epub 2011 Jun 30.
10
Genetically modified mesenchymal stem cells for improved islet transplantation.
Mol Pharm. 2011 Oct 3;8(5):1458-70. doi: 10.1021/mp200135e. Epub 2011 Jul 7.
Zotero 插件